Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Perspective Therapeutics Inc shares valued at $57,409,487 were purchased by Lantheus Alpha Therapy, LLC on Mar 06 ’24. At $0.95 per share, Lantheus Alpha Therapy, LLC acquired 60,431,039 shares. The insider’s holdings grew to 116,773,394 shares worth approximately $198.51 million following the completion of this transaction.
Also, Williamson Robert F III purchased 127,206 shares, netting a total of over 90,710 in proceeds. Following the buying of shares at $0.71 each, the insider now holds 338,761 shares.
Before that, Williamson Robert F III had added 25,266 shares to its account. In a trade valued at $16,170, the Director bought Perspective Therapeutics Inc shares for $0.64 each. Upon closing the transaction, the insider’s holdings increased to 25,266 shares, worth approximately $0.36 million.
Analyzing CATX Stock Performance
During the last five days, there has been a surge of approximately 0.59%. Over the course of the year, Perspective Therapeutics Inc shares have jumped approximately 322.89%. Shares of the company reached a 52-week high of $1.7700 on 04/24/24 and a 52-week low of $0.3799 on 01/18/24. A 50-day SMA is recorded $1.2823, while a 200-day SMA reached $0.6389. Nevertheless, trading volume fell to 3.91 million shares from 4.23 million shares the previous day.
Support And Resistance Levels for Perspective Therapeutics Inc (CATX)
According to the 24-hour chart, there is a support level at 1.6467, which, if violated, would cause prices to drop to 1.5933. In the upper region, resistance lies at 1.7517. The next price resistance is at 1.8033. RSI (Relative Strength Index) is 66.64 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.1033, which suggests the price will decrease in the coming days. Percent R is at 14.58%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
